Related Experiment Video
Updated: Jan 14, 2026

Focal Laser Ablation of Prostate Cancer: An Office Procedure
Published on: March 30, 2021
Updates on Prostate Arterial Embolization
Abin Sajan1, Ari Isaacson2, Sandeep Bagla2
1Department of Radiology, Columbia University Irving Medical Center, 622 West 168th Street, New York, NY 10032, USA.
None:
Lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) is a common urologic condition that is highly prevalent in aging men. This article outlines recent advancements in PAE, including long-term clinical outcomes, integration with minimally invasive surgical therapies, novel embolic agents, cost-effectiveness, radiation safety, and emerging applications in select prostate cancer populations. These developments highlight prostate artery embolization as a durable and safe therapeutic option for BPH, with growing utility across a broad spectrum of clinical scenarios. Further research should continue to refine patient selection and assess long-term outcomes of emerging embolic technologies and combination strategies.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Peripheral Artery Disease V: Postoperative Nursing Management
Pulmonary Embolism III: Nursing Management

